BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

May 10, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-05-08

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-08	Common Stock	A	24000	—	Acquired	54018	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-08	Stock Option (right to buy)	$37.46	A	60000	Acquired	2022-05-07	Common Stock (60000)	Direct

Footnotes

F1: Restricted stock units granted on May 8, 2012. Price not applicable.

F2: Options vest 6/48ths on November 8, 2012 and 1/48th on the 8th of each month thereafter.